Newsletter Archive
-
10.16.26 -- Cancer Innovation, Trial Strategy, And AI Manufacturing
10/16/2026
10/16/26 Life Science Leader Newsletter
-
10.14.26 -- Servant Leadership, AI Validation, CAR-T Advances, And Trial Success
10/14/2026
10/14/26 Life Science Leader Newsletter
-
10.12.26 -- Choosing The Right CSO For Your 2027 Product Launch
10/12/2026
10/12/26 Life Science Leader Newsletter
-
10.10.26 -- Life Science Leader Newsletter - Best Of September
10/10/2026
10/10/26 Life Science Leader Newsletter
-
10.09.26 -- Scaling Radiopharma Success: AdvanCell CEO Shares Lessons
10/9/2026
10/09/26 Life Science Leader Newsletter
-
10.08.26 -- New Insights On Advancing AAV Development And Beyond
10/8/2026
10/08/26 Life Science Leader Newsletter
-
10.05.26 -- FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know
10/5/2026
10/05/26 Life Science Leader Newsletter
-
10.02.26 -- Can Virtual Biotechs Thrive Without Institutional Capital?
10/2/2026
10/02/26 Life Science Leader Newsletter
-
10.02.26 -- New Podcast Episodes: 2026 Regulatory Updates, Funding A Virtual Biotech, Structuring CGT Deals
10/2/2026
10/02/26 Life Science Leader Newsletter
-
09.30.26 -- FDA Engagement Strategies And Best Practices Amid Agency Changes
9/30/2026
09/30/26 Life Science Leader Newsletter